<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00618033</url>
  </required_header>
  <id_info>
    <org_study_id>169-07</org_study_id>
    <nct_id>NCT00618033</nct_id>
  </id_info>
  <brief_title>Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients</brief_title>
  <acronym>Dextrose</acronym>
  <official_title>Short-Term Study of Physiologic Dialysate Glucose Concentration in Chronic Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renal Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Renal Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the
      dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with
      regard to the frequency and magnitude of blood glucose drops. Other parameters that will be
      compared between the two groups are blood pressure, heart rhythm, weight gain between
      dialysis treatments, and fatigue after the treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, single-blinded cross-over non-inferiority trial of intra-
      and early post-dialytic glucose homeostasis comparing 100 mg/dL against 200 mg/dL dialysate
      glucose concentration in 30 hemodialysis patients. The primary outcome is the frequency and
      magnitude of hypoglycemia during and early after the hemodialysis treatment. Secondary
      outcomes include intradialytic blood pressure, interdialytic weight gain, serum potassium and
      phosphorus concentrations, arrhythmias during dialysis and in the early postdialytic period,
      and postdialytic fatigue.

      Inclusion criteria:

      Age ≥ 18 years

      Maintenance hemodialysis with hemodialysis vintage of at least 30 days

      Ability to read and understand the English language and give informed consent

      Exclusion criteria:

      Dialysis treatment frequencies other than three times per week

      Hospitalizations or antibiotics-dependent infection during the 8 weeks preceding enrollment

      Central venous catheter as hemodialysis access
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency and magnitude of hypoglycemia during and early after the hemodialysis treatment</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intradialytic blood pressure, interdialytic weight gain, serum potassium and phosphorus concentrations, arrhythmias during dialysis and in the early postdialytic period, postdialytic fatigue</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hemodialysis</condition>
  <condition>ESRD</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemodialysis</intervention_name>
    <description>varying concentration of glucose in dialysate</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Maintenance hemodialysis with hemodialysis vintage of at least 30 days

          -  Ability to read and understand the English language and give informed consent

        Exclusion Criteria:

          -  Dialysis treatment frequencies other than three times per week

          -  Hospitalisations or antibiotics-dependent infection during the 8 weeks preceding
             enrollment

          -  Central venous catheter as hemodialysis access
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan W. Levin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renal Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Irving Place Dialysis Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yorkville Dialysis Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Raimann JG, Kruse A, Thijssen S, Kuntsevich V, Diaz-Buxo JA, Levin NW, Kotanko P. Fatigue in hemodialysis patients with and without diabetes: results from a randomized controlled trial of two glucose-containing dialysates. Diabetes Care. 2010 Sep;33(9):e121. doi: 10.2337/dc10-1043.</citation>
    <PMID>20805263</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferrario M, Raimann JG, Thijssen S, Signorini MG, Kruse A, Diaz-Buxo JA, Cerutti S, Levin NW, Kotanko P. Effects of dialysate glucose concentration on heart rate variability in chronic hemodialysis patients: results of a prospective randomized trial. Kidney Blood Press Res. 2011;34(5):334-43. doi: 10.1159/000327851. Epub 2011 May 25.</citation>
    <PMID>21613795</PMID>
  </results_reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2008</study_first_submitted>
  <study_first_submitted_qc>February 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2008</study_first_posted>
  <last_update_submitted>June 8, 2011</last_update_submitted>
  <last_update_submitted_qc>June 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Nathan Levin, MD</name_title>
    <organization>Renal Research Institute</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>ESRD</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dialysis Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

